ZYBT

$1.380.73%0.010

After Hours: 1.380.00 0.00%

Zhengye Biotechnology Holding Ltd (ZYBT)

Zhengye Biotechnology Holding Ltd Stock (ZYBT) Forecast

The Zhengye Biotechnology Holding Ltd (ZYBT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.44, representing a +4.42% increase from the current price of $1.38. The highest analyst price target is $2.07, and the lowest is $0.8122.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month ZYBT Price Target

Average 5.73 (+315.00% Upside)

Is Zhengye Biotechnology Holding Ltd (ZYBT) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	48.20	Neutral
STOCH(9,6)	42.68	Neutral
STOCHRSI(14)	49.85	Neutral
MACD(12,26)	-0.02	Sell
ADX(14)	46.75	Buy
William %R	-46.15	Neutral
CCI(14)	-35.86	Neutral

Buy: 1 · Sell: 1 · Neutral: 5Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	1.39 Sell	1.38 Sell
MA20	1.46 Sell	1.40 Sell
MA50	1.43 Sell	1.42 Sell
MA100	1.42 Sell	1.41 Sell
MA200	1.16 Buy	1.82 Sell

Buy: 1 · Sell: 9 · Neutral: 0Summary: Sell

According to our latest analysis, ZYBT could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on ZYBT, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 48.20 indicates that ZYBT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 42.68 indicates that ZYBT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 49.85 indicates that ZYBT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
ADX (Average Directional Index): The ADX value of 46.75 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
CCI (Commodity Channel Index): A CCI(14) value of -35.86 indicates that ZYBT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term ZYBT price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Zhengye Biotechnology Holding Ltd financial reports and earnings history, Zhengye Biotechnology Holding Ltd (ZYBT) stock could reach $5.31 by 2030, $13.13 by 2040 and $25.05 by 2050. See the projected annual prices until 2050 of the Zhengye Biotechnology Holding Ltd stock below:

Zhengye Biotechnology Holding Ltd (ZYBT) is expected to reach an average price of $8.79 in 2035, with a high prediction of $11.27 and a low estimate of $2.70. This indicates an +536.65% change from the last recorded price of $1.38.
Zhengye Biotechnology Holding Ltd (ZYBT) stock is projected to chart a bullish course in 2040, with an average price target of $6.79, representing an +392.38% change from its current level. The forecast ranges from a conservative $6.83 to a sky-high $13.13.
Our analysts predict Zhengye Biotechnology Holding Ltd (ZYBT) to change +1,163% by 2045, soaring from $7.65 to an average price of $17.43, potentially reaching $27.24. While $7.65 is the low estimate, the potential upside is significant.
Zhengye Biotechnology Holding Ltd (ZYBT) stock is expected to climb by 2050, reaching an average of $17.14, a +1,142% change from its current level. However, a wide range of estimates exists, with high and low targets of $25.05 and $17.17, respectively, highlighting the market's uncertainty.

Zhengye Biotechnology Holding Ltd Stock (ZYBT) Year by Year Forecast

Zhengye Biotechnology Holding Ltd Stock (ZYBT) Price Forecast for 2026

The predicted value for Zhengye Biotechnology Holding Ltd (ZYBT) in 2026 is set at an average of $1.11. Estimates vary from a peak of $8.01 to a trough of $0.6155, indicating an -19.93% surge from the present price of $1.38.

Month	Average	Low	High	Change from today's price
December, 2026	$1.12	$0.8122	$2.07	-18.68%

Zhengye Biotechnology Holding Ltd Stock (ZYBT) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Zhengye Biotechnology Holding Ltd (ZYBT) is $2.73, with a high forecast of $11.42 and a low forecast of $0.0297. This indicates an +97.70% increase from the last price of $1.38.

Month	Average	Low	High	Change from today's price
January, 2027	$2.10	$0.9658	$7.00	+52.32%
February, 2027	$7.14	$0.5606	$7.55	+417.53%
March, 2027	$5.03	$1.51	$11.42	+264.34%
April, 2027	$3.61	$1.88	$7.30	+161.79%
May, 2027	$3.27	$2.78	$7.01	+136.86%
June, 2027	$2.76	$2.57	$3.55	+100.25%
July, 2027	$6.91	$2.24	$7.91	+400.60%
August, 2027	$0.2743	$0.6957	$10.65	-80.12%
September, 2027	$0.1791	$0.0582	$0.9167	-87.02%
October, 2027	$0.036	$0.116	$0.3104	-97.39%
November, 2027	$0.54	$0.0297	$0.2752	-60.87%
December, 2027	$0.8852	$0.8852	$0.8476	-35.85%

Zhengye Biotechnology Holding Ltd Stock (ZYBT) Price Forecast for 2028

In 2028, Zhengye Biotechnology Holding Ltd (ZYBT) is projected to reach an average price of $0.8234, with a high projection of $6.66 and a low estimate of $0.0165. This indicates an -40.34% fall from the last price of $1.38.

Month	Average	Low	High	Change from today's price
January, 2028	$0.9992	$0.924	$0.9116	-27.59%
February, 2028	$1.08	$1.08	$1.00	-21.42%
March, 2028	$0.6496	$0.8596	$0.8171	-52.93%
April, 2028	$0.7048	$0.7284	$0.7048	-48.93%
May, 2028	$0.6882	$0.7121	$0.6699	-50.13%
June, 2028	$0.7568	$0.6974	$0.7139	-45.16%
July, 2028	$0.00209	$0.1591	$6.66	-99.85%
August, 2028	$0.4869	$0.0887	$2.98	-64.72%
September, 2028	$0.2117	$0.1649	$0.5893	-84.66%
October, 2028	$0.3477	$0.0165	$1.82	-74.80%
November, 2028	$1.86	$0.1601	$0.6234	+34.51%
December, 2028	$2.09	$2.19	$1.80	+51.65%

Zhengye Biotechnology Holding Ltd Stock (ZYBT) Price Forecast for 2029

The 2029 price forecast for Zhengye Biotechnology Holding Ltd Stock (ZYBT) is $2.35 on average, with a high prediction of $8.55 and a low estimate of $0.0302. This represents an +70.40% increase from the previous price of $1.38.

Month	Average	Low	High	Change from today's price
January, 2029	$1.59	$1.62	$1.43	+15.27%
February, 2029	$1.63	$0.8535	$3.99	+18.20%
March, 2029	$3.36	$0.6885	$8.55	+143.37%
April, 2029	$3.48	$1.30	$8.30	+152.21%
May, 2029	$1.24	$0.1629	$4.32	-10.13%
June, 2029	$0.4898	$0.0302	$1.91	-64.51%
July, 2029	$2.52	$0.128	$3.51	+82.74%
August, 2029	$4.50	$0.2358	$8.22	+226.19%
September, 2029	$1.97	$2.44	$6.68	+42.68%
October, 2029	$2.39	$1.93	$1.93	+72.96%
November, 2029	$2.12	$2.16	$2.10	+53.79%
December, 2029	$2.93	$2.29	$2.88	+111.97%

Zhengye Biotechnology Holding Ltd Stock (ZYBT) Price Forecast for 2030

Zhengye Biotechnology Holding Ltd Stock (ZYBT) is expected to reach an average price of $2.15 in 2030, with a high forecast of $5.31 and a low forecast of $0.6421. This signifies an +55.44% surge from the last price of $1.38.

Month	Average	Low	High	Change from today's price
January, 2030	$2.91	$2.87	$2.84	+110.67%
February, 2030	$2.92	$2.95	$2.83	+111.30%
March, 2030	$2.70	$2.81	$2.82	+95.90%
April, 2030	$2.41	$2.42	$2.57	+74.96%
May, 2030	$2.21	$2.29	$2.33	+60.32%
June, 2030	$2.16	$2.19	$2.21	+56.87%
July, 2030	$2.00	$2.15	$2.15	+45.15%
August, 2030	$0.7234	$1.40	$5.31	-47.58%
September, 2030	$0.7914	$0.7438	$0.6638	-42.65%
October, 2030	$1.03	$0.809	$0.8941	-25.24%
November, 2030	$0.5621	$0.6421	$0.9013	-59.27%
December, 2030	$5.31	$0.7273	$4.88	+284.88%

Similar to ZYBT